Matrine and Oxymatrine: evaluating the gene mutation potential using <i>in silico</i> tools and the bacterial reverse mutation assay (Ames test)
Benjamin Christian Fischer(Federal Institute for Risk Assessment), Kristin Herrmann(Federal Institute for Risk Assessment), Stefanie Hessel‐Pras(Federal Institute for Risk Assessment), Benjamin Sachse(Federal Institute for Risk Assessment), Yemurai Musengi(Federal Institute for Risk Assessment), Carsten Kneuer, Bernd Schäfer(Federal Institute for Risk Assessment), Jeannette König(Federal Institute for Risk Assessment)
Cited by 12
Related Papers
Happily (n)ever after: Aging in the context of oxidative stress, proteostasis loss and cellular senescence
|Redox Biology|2016|358
Guidance on dermal absorption
|EFSA Journal|2017|212
Genotoxicity assessment: opportunities, challenges and perspectives for quantitative evaluations of dose–response data
|Archives of Toxicology|2023|84